IPO Issue Details
Issue Price / Price Band₹248 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size60 Shares per Lot
Total Issue Size2,03,54,838 shares (aggregating up to ₹504.80 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenTue, 05 Dec 2017
Subscription CloseThu, 07 Dec 2017
Anchor AllotmentMon, 04 Dec 2017
Basis of AllotmentTue, 12 Dec 2017
Initiation of RefundsWed, 13 Dec 2017
Credit of Shares to DematThu, 14 Dec 2017
Listing DateFri, 15 Dec 2017
UPI Mandate Deadline2017-12-07
Application & Investment Details
Retail — Min (1 Lots)₹14,880 — 60 shares
Retail — Max (13 Lots)₹193,440 (13 Lots)
HNI — Min (14 Lots)₹2,08,320 — 840 shares
Pre-IPO Promoter Holding8,86,54,932 shares
Post-IPO Promoter Holding10,80,09,770 shares
Fresh Issue Shares1,93,54,838 shares (aggregating up to ₹480.00 Cr)
Offer for Sale Shares10,00,000 shares of ₹10 (aggregating up to ₹24.80 Cr)
About Shalby Ltd.
Incorporated in 2004, Shalby Limited is Ahmedabad, Gujrat based one of the leading multi-specialty chain of hospitals in India. Company provides inpatient and outpatient healthcare services through 8 fully operational hospitals with an aggregate operational bed count of 781 beds. Company also provides outpatient consultative healthcare services through 3 hospitals and 68 Outpatient Clinics. Company has 8 shared surgery centers within third party hospitals.Shalby hospitals are well known for its orthopaedic services. Shalby Hospital had a 15% market share of all joint replacement surgeries conducted by private corporate hospitals in India in 2016. Apart from a focus on orthopaedics, Shalby hospitals provide advanced levels of care across various specialties such as neurology, cardiac care, critical care, oncology, and nephrology.Since March 2007, Shalby hospitals have conducted an aggregate of 84,579 surgeries, and provided healthcare services to an aggregate of 923,441 patients, consisting 121,576 inpatients and 801,865 outpatients.Shalby hospitals operate across five states and Outpatient Clinics operate across 53 cities in 16 states in India. Company also has six Outpatient Clinics and one Shalby Arthroplasty Centre of Excellence (SACE) in Africa, and two SACE in the UAE.Shalby hospital is led by Dr Vikram Shah, an orthopaedic surgeon with more than 25 years of professional experience. Dr Vikram Shah is one of the promoters of the company.As of December 31, 2016, Shalby hospital employed 1,599 employees and engaged 267 professional consultants, consisting 242 doctors who are full-time consultants and 25 doctors who are part-time consultants. Hospital's staff strength also comprises 458 nurses and 1,141 paramedical, corporate and support staff and pharmacists.
Objects of the Issue
Shalby Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Repayment or prepayment in full or in part of certain loans availed byour Company
300.00
2
2 Purchase of medical equipment for existing,recently set up and upcoming hospitals
63.58
3
3 Purchase of interiors, furniture, and allied infrastructure for upcoming hospitals
11.18
4
4 General corporate purposes
81.66
Shareholding & Lock-in
Pre-IPO Promoter Holding
8,86,54,932 shares
Post-IPO Promoter Holding
10,80,09,770 shares
Lock-in Period (30%)January 11, 2018
Lock-in Period (50%)March 12, 2018